Anya Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	150.75	290.22	11.46	2.07
Short-Term Investments	219.47	163.93	-	-
Cash & Short-Term Investments	370.22	454.15	11.46	2.07
Cash Growth	-18.48%	3864.28%	454.50%	-
Accounts Receivable	11.88	3.4	0.17	0.56
Other Receivables	5.02	2.8	-	0.75
Receivables	16.9	6.2	0.17	1.31
Prepaid Expenses	4.61	0.85	-	1.46
Other Current Assets	0.97	0.68	1.41	0.76
Total Current Assets	392.7	461.88	13.03	5.6
Property, Plant & Equipment	8.74	9.15	1.72	2.5
Other Intangible Assets	5.99	5.08	5.08	0.6
Other Long-Term Assets	6.46	5.22	2.4	2.86
Total Assets	413.87	481.32	22.23	11.56
Accrued Expenses	6.99	6.47	1.85	1.38
Short-Term Debt	-	-	102.01	63.28
Current Portion of Leases	0.12	0.17	0.95	0.82
Current Unearned Revenue	-	3.23	-	-
Other Current Liabilities	1.08	1.24	0.61	0.36
Total Current Liabilities	8.19	11.11	105.41	65.84
Long-Term Leases	2.83	3.25	0.08	0.9
Total Liabilities	11.02	14.36	105.49	66.74
Common Stock	491.02	491.02	8.77	8.77
Additional Paid-In Capital	14.82	14.82	16.38	16.38
Retained Earnings	-102.85	-38.83	-108.39	-80.31
Comprehensive Income & Other	-0.16	-0.13	-0.04	-0.04
Total Common Equity	402.83	466.89	-83.28	-55.19
Minority Interest	0.02	0.08	0.01	0.02
Shareholders' Equity	402.85	466.97	-83.26	-55.18
Total Liabilities & Equity	413.87	481.32	22.23	11.56
Total Debt	2.96	3.41	103.03	65
Net Cash (Debt)	367.26	450.73	-91.58	-62.93
Net Cash Growth	-18.52%	-	-	-
Net Cash Per Share	7.48	13.62	-40.16	-27.60
Filing Date Shares Outstanding	49.1	49.1	8.77	2.28
Total Common Shares Outstanding	49.1	49.1	8.77	2.28
Working Capital	384.51	450.77	-92.39	-60.24
Book Value Per Share	8.20	9.51	-9.50	-24.21
Tangible Book Value	396.84	461.8	-88.36	-55.79
Tangible Book Value Per Share	8.08	9.41	-10.07	-24.47
Machinery	4.18	2.69	1	0.94
Leasehold Improvements	3.46	3.8	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.